Today, Blueprint Medicines Corp (NASDAQ: BPMC) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Most recently, Yahoo Finance reported about the stock as it publicized that Blueprint Medicines Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Blueprint Medicines Corp is $5.61B. A total of 0.57 million shares were traded on the day, compared to an average of 808.04K shares.

In the most recent transaction, Landsittel Michael sold 5,000 shares of BPMC for 95.00 per share on Mar 28 ’24. After the transaction, the CHIEF FINANCIAL OFFICER now owns 47,286 company shares. In a previous transaction on Mar 20 ’24, Albers Jeffrey W. sold 25,073 shares at 87.28 per share. BPMC shares that Director owns now total 176,050.

Among the insiders who sold shares, Landsittel Michael disposed of 13,734 shares on Mar 15 ’24 at a per-share price of $87.78. This resulted in the CHIEF FINANCIAL OFFICER holding 47,286 shares of BPMC after the transaction. In another insider transaction, Hurley Ariel sold 4,549 shares at $87.76 per share on Mar 15 ’24. Company shares held by the PRINCIPAL ACCOUNTING OFFICER now total 14,913.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, BPMC has a high of $101.00 and a low of $41.54.

As of this writing, BPMC has an earnings estimate of -$1.66 per share for the current quarter. EPS was calculated based on a consensus of 15 estimates, with a high estimate of -$1.46 per share and a lower estimate of -$1.8. The company reported an EPS of -$2.2 in the last quarter, which was 7.20% higher than expectations of -$2.37.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BPMC’s latest balance sheet shows that the firm has $477.11M in Cash & Short Term Investments as of fiscal 2021. There were $111.41M in debt and $149.76M in liabilities at the time. Its Book Value Per Share was $2.14, while its Total Shareholder’s Equity was $970.74M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BPMC is Buy with a score of 4.06.

Most Popular

Related Posts